Clinical perspective on Efinopegdutide MASH data my results so:
I have managed over 200 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that proper titration prevents most adverse events.
For this specific question, I would recommend: reviewing the relevant clinical guidelines.
Subscribing to this thread. Efinopegdutide MASH data is exactly what I've been researching. 🙏
Reading this thread on Efinopegdutide MASH data hits close to home. Dad of 2 checking in — I started at 273 lbs and felt like I would tried everything.
9 months on tirz and I am a different person. Not just the 48 lbs lost — my energy, my mood, my relationship with food. All transformed.
If you are on the fence about Efinopegdutide MASH — take the leap. It was the best health decision I have ever made. ❤️
KetoKyle said:Keep going — you're doing incredible
This is exactly right. KetoKyle articulated what I have been trying to explain to my doctor for months. The Efinopegdutide MASH data aspect is the most important factor.